Colossal: $200 Million (Series C) Raised At $10.2 Billion Valuation For De-Extinction Technology
By Amit Chowdhry ● Yesterday at 1:29 AM
De-extinction company Colossal Biosciences announced $200 million in a Series C funding round by TWG Global, jointly led by Mark Walter and Thomas Tull. And Colossal’s additional strategic investors include funds such as USIT, Animal Capital, Breyer Capital, At One Ventures, In-Q-Tel, BOLD Capital, Peak 6, and Draper Associates, and others and private investors including Robert Nelsen, Peter Jackson, Fran Walsh, Ric Edelman, Brandon Fugal, Paul Tudor Jones, Richard Garriott, Giammaria Giuliani, Sven-Olof Lindblad, Victor Vescovo, and Jeff Wilke.